Skip to main content
Year archive

POLYNOVO LIMITED — 2006 filings

All 59 regulatory filings released by POLYNOVO LIMITED (PNV) in 2006, sourced directly from the official regulator.

59 Filings
2006 Period
2006 filings (59)
Filing Released Lang
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2006-12-27 English
Open Briefing.Metabolic.CEO on Obesity Drug Trial 5 pages ?Kb
Investor Presentation
2006-12-19 English
Audio Broadcast - CEO Interviewed by Boardroom Radio 2 pages ?Kb
Regulatory Filings
2006-12-18 English
Completes Phase 2B Obesity Trial 4 pages ?Kb
Regulatory Filings
2006-12-17 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2006-12-14 English
Cleansing statement re Section 708A 1 page ?Kb
Capital/Financing Update
2006-12-14 English
Change in substantial holding 2 pages ?Kb
Major Shareholding Notification
2006-12-14 English
Trading Halt 1 page ?Kb
Regulatory Filings
2006-12-06 English
Trading Halt Request 1 page ?Kb
Capital/Financing Update
2006-12-06 English
Metabolic completes A$10.5 million share placement 3 pages ?Kb
Capital/Financing Update
2006-12-06 English
Open Briefing.Metabolic.CEO on Strategy 7 pages ?Kb
Investor Presentation
2006-12-04 English
Metabolics pain drug ACV1 - clinical trials update 3 pages ?Kb
Capital/Financing Update
2006-11-28 English
Obesity Trial - Over 300 subjects completed so far 3 pages ?Kb
Regulatory Filings
2006-11-26 English
Corporate Presentation for Domestic Roadshow 26 pages ?Kb
Investor Presentation
2006-11-26 English
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification
2006-11-23 English
Metabolics neuropathic pain drug ACV1 preclinical update 3 pages ?Kb
Capital/Financing Update
2006-11-22 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-11-19 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2006-11-16 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-11-16 English
2006 AGM - Chairmans address & CEO presentation 58 pages ?Kb
AGM Information
2006-10-26 English
2006 AGM - Voting Results 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2006-10-26 English
Constitution 56 pages ?Kb
Governance Information
2006-10-26 English
Amendment to Change in substantial holding 3 pages ?Kb
Major Shareholding Notification
2006-10-22 English
Amended Change in substantial holding 3 pages ?Kb
Major Shareholding Notification
2006-10-22 English
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification
2006-10-19 English
Quarterly Investor Update 4 pages ?Kb
Interim / Quarterly Report
2006-10-16 English
Response to ASX Query 5 pages ?Kb
Regulatory Filings
2006-10-16 English
CEO presents at Intersuisse Life Sciences Forum (London) 48 pages ?Kb
Investor Presentation
2006-10-11 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2006-10-08 English
Obesity Trial Update:First 100 Subjects Complete Trial 3 pages ?Kb
Regulatory Filings
2006-10-04 English
CEO presents at UBS Global Life Sciences Conference (NY) 45 pages ?Kb
Investor Presentation
2006-09-27 English
Neuropathic Pain Drug ACV1 Enters Phase 2 Clinical Trials 4 pages ?Kb
Capital/Financing Update
2006-09-26 English
Annual Report/Notice of AGM 105 pages ?Kb
Annual Report
2006-09-25 English
Preliminary Final Report 40 pages ?Kb
Annual Report
2006-08-27 English
Q0uarterly Investor Update 6 pages ?Kb
Interim / Quarterly Report Q2 2006
2006-07-26 English
Obesity Trial Update: First subject completes treatment 3 pages ?Kb
Regulatory Filings
2006-07-18 English
Investor Roadshow - UK & Europe 2 pages ?Kb
Investor Presentation
2006-07-02 English
Osteoporosis drug - additional animal data 3 pages ?Kb
Regulatory Filings
2006-06-20 English
CEO Presents at Life Sciences Conference 33 pages ?Kb
Investor Presentation
2006-06-13 English
Company Presentation 34 pages ?Kb
Investor Presentation
2006-05-22 English
Quarterly Investor Update 7 pages ?Kb
Interim / Quarterly Report
2006-05-09 English
Audio Broadcast - CEO Interviewed 2 pages ?Kb
Investor Presentation
2006-05-07 English
Completes enrolment for obesity trial ahead of schedule 3 pages ?Kb
Regulatory Filings
2006-05-01 English
CEO To Present at US Biotech Conferences 36 pages ?Kb
Investor Presentation
2006-04-04 English
Change in substantial holding 7 pages ?Kb
Major Shareholding Notification
2006-03-28 English
Notice under section 708A(5)(e) 1 page ?Kb
Capital/Financing Update
2006-03-23 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2006-03-23 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2006-03-23 English
Raises A$13m in private placement 3 pages ?Kb
Capital/Financing Update
2006-03-20 English
Trading Halt 2 pages ?Kb
Capital/Financing Update
2006-03-16 English
Clinical Trials Update 2 pages ?Kb
Investor Presentation
2006-03-05 English
Half Yearly Report & Half Year Accounts 21 pages ?Kb
Interim / Quarterly Report
2006-02-26 English
CEO to present at BioCEO &I nvestor Conference in New York 2 pages ?Kb
Investor Presentation
2006-02-14 English
Corporate Presentation - Market Update February 2006 38 pages ?Kb
Investor Presentation
2006-02-07 English
Quarterly Investor Update no.12 6 pages ?Kb
Interim / Quarterly Report Q4 2005
2006-02-05 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2006-01-31 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2006-01-31 English
Potential new use in osteoporosis adds value to obesity drug 3 pages ?Kb
Regulatory Filings
2006-01-30 English
Update on Phase 2B dosing trial for obesity drug 2 pages ?Kb
Regulatory Filings
2006-01-22 English